- Home
- SVA vs DVAX Comparison
SVA vs DVAX Comparison
Compare SVA & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- DVAX
- Stock Information
- Founded
- SVA N/A
- DVAX 1996
- Country
- SVA
- DVAX United States
- Employees
- SVA 3261
- DVAX N/A
- Industry
- SVA
- DVAX Biotechnology: Pharmaceutical Preparations
- Sector
- SVA
- DVAX Health Care
- Exchange
- SVA NYSE
- DVAX Nasdaq
- Market Cap
- SVA N/A
- DVAX N/A
- IPO Year
- SVA N/A
- DVAX 2004
- Fundamental
- Price
- SVA $6.47
- DVAX $10.30
- Analyst Decision
- SVA
- DVAX Buy
- Analyst Count
- SVA 0
- DVAX 4
- Target Price
- SVA N/A
- DVAX $26.25
- AVG Volume (30 Days)
- SVA N/A
- DVAX 1.7M
- Earning Date
- SVA N/A
- DVAX 08-05-2025
- Dividend Yield
- SVA N/A
- DVAX N/A
- EPS Growth
- SVA N/A
- DVAX N/A
- EPS
- SVA N/A
- DVAX N/A
- Revenue
- SVA N/A
- DVAX $294,620,000.00
- Revenue This Year
- SVA N/A
- DVAX $21.18
- Revenue Next Year
- SVA N/A
- DVAX $16.83
- P/E Ratio
- SVA N/A
- DVAX N/A
- Revenue Growth
- SVA N/A
- DVAX 24.76
- 52 Week Low
- SVA N/A
- DVAX $9.22
- 52 Week High
- SVA N/A
- DVAX $14.63
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- DVAX 54.89
- Support Level
- SVA N/A
- DVAX $9.79
- Resistance Level
- SVA N/A
- DVAX $10.38
- Average True Range (ATR)
- SVA 0.00
- DVAX 0.35
- MACD
- SVA 0.00
- DVAX 0.05
- Stochastic Oscillator
- SVA 0.00
- DVAX 63.11
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.